A detailed history of Lynch & Associates transactions in Cvs Health Corp stock. As of the latest transaction made, Lynch & Associates holds 25,895 shares of CVS stock, worth $1.16 Million. This represents 0.35% of its overall portfolio holdings.

Number of Shares
25,895
Previous 27,721 6.59%
Holding current value
$1.16 Million
Previous $1.64 Million 0.61%
% of portfolio
0.35%
Previous 0.37%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

SELL
$55.81 - $63.18 $101,909 - $115,366
-1,826 Reduced 6.59%
25,895 $1.63 Million
Q2 2024

Aug 06, 2024

SELL
$53.63 - $79.56 $86,076 - $127,693
-1,605 Reduced 5.47%
27,721 $1.64 Million
Q1 2024

Apr 09, 2024

SELL
$71.99 - $81.42 $41,106 - $46,490
-571 Reduced 1.91%
29,326 $2.34 Million
Q4 2023

Jan 08, 2024

SELL
$66.29 - $79.0 $70,201 - $83,661
-1,059 Reduced 3.42%
29,897 $2.36 Million
Q3 2023

Oct 24, 2023

SELL
$65.17 - $76.41 $212,454 - $249,096
-3,260 Reduced 9.53%
30,956 $2.16 Million
Q2 2023

Oct 24, 2023

SELL
$66.65 - $77.75 $483,079 - $563,532
-7,248 Reduced 17.48%
34,216 $2.37 Million
Q2 2023

Jul 13, 2023

SELL
$66.65 - $77.75 $483,079 - $563,532
-7,248 Reduced 17.48%
34,216 $2.37 Million
Q1 2023

Oct 24, 2023

BUY
$72.37 - $92.89 $524,537 - $673,266
7,248 Added 21.18%
41,464 $3.08 Million
Q1 2023

Apr 04, 2023

SELL
$72.37 - $92.89 $307,283 - $394,410
-4,246 Reduced 9.29%
41,464 $3.08 Million
Q4 2022

Oct 24, 2023

BUY
$88.25 - $103.78 $1.3 Million - $1.53 Million
14,754 Added 47.66%
45,710 $4.26 Million
Q4 2022

Jan 05, 2023

SELL
$88.25 - $103.78 $50,743 - $59,673
-575 Reduced 1.24%
45,710 $4.26 Million
Q3 2022

Oct 03, 2022

BUY
$92.53 - $106.43 $482,543 - $555,032
5,215 Added 12.7%
46,285 $4.41 Million
Q2 2022

Jul 06, 2022

BUY
$88.66 - $106.64 $34,045 - $40,949
384 Added 0.94%
41,070 $3.81 Million
Q1 2022

Apr 08, 2022

BUY
$100.77 - $110.83 $56,028 - $61,621
556 Added 1.39%
40,686 $4.12 Million
Q4 2021

Jan 11, 2022

BUY
$83.15 - $103.7 $332,849 - $415,111
4,003 Added 11.08%
40,130 $4.14 Million
Q3 2021

Oct 12, 2021

BUY
$80.05 - $87.47 $162,581 - $177,651
2,031 Added 5.96%
36,127 $3.07 Million
Q2 2021

Jul 21, 2021

BUY
$73.79 - $89.81 $732,144 - $891,094
9,922 Added 41.04%
34,096 $2.85 Million
Q1 2021

Apr 09, 2021

BUY
$68.13 - $76.3 $335,949 - $376,235
4,931 Added 25.62%
24,174 $1.82 Million
Q4 2020

Jan 20, 2021

BUY
$55.93 - $74.5 $105,819 - $140,954
1,892 Added 10.9%
19,243 $1.31 Million
Q3 2020

Oct 21, 2020

BUY
$56.71 - $65.71 $71,171 - $82,466
1,255 Added 7.8%
17,351 $1.01 Million
Q2 2020

Jul 20, 2020

BUY
$55.41 - $70.62 $289,794 - $369,342
5,230 Added 48.13%
16,096 $1.05 Million
Q1 2020

Apr 28, 2020

SELL
$52.3 - $76.05 $7,478 - $10,875
-143 Reduced 1.3%
10,866 $645,000
Q4 2019

Jan 10, 2020

BUY
$60.38 - $76.58 $19,140 - $24,275
317 Added 2.96%
11,009 $818,000
Q3 2019

Oct 03, 2019

BUY
$54.09 - $64.3 $68,802 - $81,789
1,272 Added 13.5%
10,692 $674,000
Q2 2019

Jul 19, 2019

BUY
$52.13 - $57.33 $491,064 - $540,048
9,420 New
9,420 $513,000

Others Institutions Holding CVS

About CVS HEALTH Corp


  • Ticker CVS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Healthcare Plans
  • Shares Outstandng 1,312,829,952
  • Market Cap $59B
  • Description
  • CVS Health Corporation provides health services in the United States. The company's Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governme...
More about CVS
Track This Portfolio

Track Lynch & Associates Portfolio

Follow Lynch & Associates and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lynch & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Lynch & Associates with notifications on news.